These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 22581864

  • 21. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
    Chang JY, Liu H, Balter P, Komaki R, Liao Z, Welsh J, Mehran RJ, Roth JA, Swisher SG.
    Radiat Oncol; 2012 Sep 10; 7():152. PubMed ID: 22963661
    [Abstract] [Full Text] [Related]

  • 22. Feasible Optimization of Stereotactic Ablative Radiotherapy Dose by Tumor Size for Stage I Non-small-cell Lung Cancer.
    Lee S, Song SY, Kim SS, Choi W, Je HU, Back GM, Cho B, Jeong SY, Choi EK.
    Clin Lung Cancer; 2018 Mar 10; 19(2):e253-e261. PubMed ID: 29196082
    [Abstract] [Full Text] [Related]

  • 23. The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy - a nationwide cohort study.
    de Ruiter JC, van der Noort V, van Diessen JNA, Smit EF, Damhuis RAM, Hartemink KJ, ESLUNG group.
    Lung Cancer; 2024 May 10; 191():107792. PubMed ID: 38621343
    [Abstract] [Full Text] [Related]

  • 24. Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial.
    Palma DA, Chen H, Bahig H, Gaede S, Harrow S, Laba JM, Qu XM, Rodrigues GB, Yaremko BP, Yu E, Louie AV, Dhaliwal I, Ryerson CJ.
    BMC Cancer; 2019 Dec 11; 19(1):1206. PubMed ID: 31829203
    [Abstract] [Full Text] [Related]

  • 25. A comparison between accelerated hypofractionation and stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC): Results of a propensity score-matched analysis.
    Chiang A, Thibault I, Warner A, Rodrigues G, Palma D, Soliman H, Jain S, Poon I, Cheung P.
    Radiother Oncol; 2016 Mar 11; 118(3):478-84. PubMed ID: 26795773
    [Abstract] [Full Text] [Related]

  • 26. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
    Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, Senan S.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):348-53. PubMed ID: 22104360
    [Abstract] [Full Text] [Related]

  • 27. Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study.
    Sahin B, Atalar B, Kaytan Saglam E, Akgun Z, Abacioglu U, Arifoglu A, Ozyar E, Yaprak G, Ozseker Isik N, Guney Y, Caglar HB, Karaman S, Igdem S, Selek U, Berber T, Oner Dincbas F, Sengoz M, Yucel S, Demiral AN, Akyurek S.
    Clin Respir J; 2020 Nov 01; 14(11):1050-1059. PubMed ID: 32749053
    [Abstract] [Full Text] [Related]

  • 28. Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time?
    Das M, Abdelmaksoud MH, Loo BW, Kothary N.
    Curr Treat Options Oncol; 2010 Jun 01; 11(1-2):24-35. PubMed ID: 20577833
    [Abstract] [Full Text] [Related]

  • 29. Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort.
    Murray L, Ramasamy S, Lilley J, Snee M, Clarke K, Musunuru HB, Needham A, Turner R, Sangha V, Flatley M, Franks K.
    Clin Oncol (R Coll Radiol); 2016 Jan 01; 28(1):4-12. PubMed ID: 26474546
    [Abstract] [Full Text] [Related]

  • 30. Long-term Observation of CT-guided Radiofrequency Ablation of Lung Neoplasm in 476 Consecutive Patients by a Thoracic Surgical Service: A Single-institutional Experience.
    Huang BY, Zhou JJ, Yu ZQ, Song XY, Lin Y, Li XM, Li L.
    Acad Radiol; 2017 Dec 01; 24(12):1517-1525. PubMed ID: 28888381
    [Abstract] [Full Text] [Related]

  • 31. Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience.
    Thibault I, Poon I, Yeung L, Erler D, Kim A, Keller B, Lochray F, Jain S, Soliman H, Cheung P.
    Clin Oncol (R Coll Radiol); 2014 Nov 01; 26(11):713-9. PubMed ID: 25085765
    [Abstract] [Full Text] [Related]

  • 32. Is microwave ablation an alternative to stereotactic ablative body radiotherapy in patients with inoperable early-stage primary lung cancer?
    Watson RA, Tol I, Gunawardana S, Tsakok MT.
    Interact Cardiovasc Thorac Surg; 2019 Oct 01; 29(4):539-543. PubMed ID: 31157860
    [Abstract] [Full Text] [Related]

  • 33. Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer.
    Brooks ED, Sun B, Feng L, Verma V, Zhao L, Gomez DR, Liao Z, Jeter M, O'Reilly M, Welsh JW, Nguyen QN, Erasmus JJ, Eapen G, Ahrar K, Antonoff MB, Hahn SM, Heymach JV, Rice DC, Chang JY.
    JAMA Netw Open; 2018 Aug 03; 1(4):e181390. PubMed ID: 30646121
    [Abstract] [Full Text] [Related]

  • 34. Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort.
    Soldà F, Lodge M, Ashley S, Whitington A, Goldstraw P, Brada M.
    Radiother Oncol; 2013 Oct 03; 109(1):1-7. PubMed ID: 24128806
    [Abstract] [Full Text] [Related]

  • 35. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
    Allibhai Z, Taremi M, Bezjak A, Brade A, Hope AJ, Sun A, Cho BC.
    Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):1064-70. PubMed ID: 24210082
    [Abstract] [Full Text] [Related]

  • 36. [CT Guided Radiofrequency Ablation Followed Intratumoral Chemotherapy 
in the Treatment of Early Stage Non-small Cell Lung Cancer].
    Feng W, Li J, Han S, Tang J, Yao J, Cui Y, Wang C, Chen Z, Li X, Zhi X.
    Zhongguo Fei Ai Za Zhi; 2016 May 20; 19(5):269-78. PubMed ID: 27215455
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study.
    Ferrero C, Badellino S, Filippi AR, Focaraccio L, Giaj Levra M, Levis M, Moretto F, Torchio R, Ricardi U, Novello S.
    Lung Cancer; 2015 Sep 20; 89(3):350-6. PubMed ID: 26164208
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.